Samuel Reich
Chief Executive Officer at SAB BIOTHERAPEUTICS, INC.
Net worth: 99 426 $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eddie Sullivan | M | 58 |
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 10 years |
| Adam Logal | M | 46 |
eXegenics, Inc.
| 17 years |
| Christine Hamilton | F | 68 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 10 years |
| Phillip Frost | M | 87 |
eXegenics, Inc.
| 17 years |
| Jeffrey Spragens | M | 82 | 3 years | |
| Eddie Hamilton | M | - |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 10 years |
| David Link | M | 69 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 3 years |
| Mervyn Turner | M | 77 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 4 years |
| William Polvino | M | 63 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 5 years |
| Melissa Ullerich | F | - | 4 years | |
| Christoph Bausch | M | 53 | 7 years | |
| Russell Beyer | M | 69 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 3 years |
| Thomas Luke | M | 62 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 6 years |
| Charles Randall | M | 61 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 3 years |
| Scott Giberson | M | - | 2 years | |
| Erick Lucera | M | 57 | 1 years | |
| Richard Pfenniger | M | 68 | 16 years | |
| Alexandra Kropotova | M | 51 | 2 years | |
| Kipp Erickson | M | 62 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The private company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | 3 years |
| Katie Ellias | F | - | 1 years | |
| Andrew V. Schally | M | - |
Biscayne Pharmaceuticals, Inc.
 Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Biscayne Pharmaceuticals, Inc. develops drugs and pharmaceutical products. It offers drugs for CNS disorders such as refractory epilepsy and drug-resistant cancer. The firm also provides cancer therapies that block growth hormone-releasing hormone (GHRH) receptors. The company was founded by Andrew V. Schally and Samuel J. Reich in 2012 and is headquartered in Miami, FL. | 12 years |
| Michael King | M | 63 | 1 years | |
| Andrew Moin | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen D. Collins | M | - |
Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Biscayne Pharmaceuticals, Inc. develops drugs and pharmaceutical products. It offers drugs for CNS disorders such as refractory epilepsy and drug-resistant cancer. The firm also provides cancer therapies that block growth hormone-releasing hormone (GHRH) receptors. The company was founded by Andrew V. Schally and Samuel J. Reich in 2012 and is headquartered in Miami, FL. | 1 years |
| Dale Pfost | M | - |
Acuity Pharmaceuticals, Inc.
 Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA.
eXegenics, Inc.
| 4 years |
| Dave A. Eichler | M | - |
eXegenics, Inc.
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | - |
| Michael Reich | M | 81 |
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA.
eXegenics, Inc.
| 6 years |
| Richard Alan Lerner | M | 85 |
eXegenics, Inc.
| 14 years |
| Jack Levine | M | 73 |
Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Biscayne Pharmaceuticals, Inc. develops drugs and pharmaceutical products. It offers drugs for CNS disorders such as refractory epilepsy and drug-resistant cancer. The firm also provides cancer therapies that block growth hormone-releasing hormone (GHRH) receptors. The company was founded by Andrew V. Schally and Samuel J. Reich in 2012 and is headquartered in Miami, FL. | - |
| Ben Bronstein | M | 74 | 1 years | |
| Jane Hsaio | M | 77 |
eXegenics, Inc.
| - |
| Todd M. Wallach | M | - |
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | 5 years |
| Pascal J. Goldschmidt | M | - | 4 years | |
| James Martin | M | 58 | 1 years | |
| Melvin L. Rubin | M | - |
eXegenics, Inc.
| - |
| Steven Verdooner | M | - |
eXegenics, Inc.
| - |
| Subbarao V. Uppaluri | M | 75 |
eXegenics, Inc.
| - |
| Melvin D. Rubin | M | - | - | |
| Ilan Katz | M | 52 | - | |
| George Lasezkay | M | 72 |
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | - |
| Gordon F. Martin | M | - |
eXegenics, Inc.
| - |
| Roger J. Guidi | M | - |
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Acuity Pharmaceuticals, Inc. developed pharmaceutical products. The company used proprietary technology for the treatment and prevention of ophthalmic diseases. It developed drugs for age related macular degeneration and diabetic macular edema. Acuity Pharmaceuticals was founded in 2002 and was headquartered in Philadelphia, PA. | - |
| Frederick Finnegan | M | 64 | 4 years | |
| Denis O'Shaughnessy | M | 73 |
eXegenics, Inc.
| - |
| John Paganelli | M | 89 |
eXegenics, Inc.
| - |
| John Huntz | M | 74 |
eXegenics, Inc.
| - |
| Naveed Shams | M | 67 | 1 years | |
| Robert A. Baron | M | 84 |
eXegenics, Inc.
| - |
| Steven Rubin | M | 63 |
eXegenics, Inc.
| - |
| Thomas E. Beier | M | 78 | - | |
| Daniel Haines | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 51 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Samuel Reich
- Personal Network
